Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1Terminated 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Keratosis, Actinic 3Glioma 3Glioblastoma 2Carcinoma, Basal Cell 2Brain Neoplasms 2Skin Neoplasms 1Pituitary Neoplasms 1Oligodendroglioma 1Neuroectodermal Tumors 1Neoplasms, Neuroepithelial 1Neoplasms, Basal Cell 1Neoplasms 1Neoplasm, Residual 1Neoplasm Metastasis 1Central Nervous System Neoplasms 1Carcinoma, Squamous Cell 1Astrocytoma 1

Interventions

Temozolomide 7Radiotherapy 5Vincristine 3Cisplatin 3Carmustine 3Carboplatin 3Methotrexate 2Cyclophosphamide 2Chlorotoxin 2lonafarnib 1Verteporfin 1Thiotepa 1Surgical Procedures, Operative 1Peripheral Blood Stem Cell Transplantation 1Pemetrexed 1Metabolism 1In Situ Hybridization, Fluorescence 1Immunohistochemistry 1Gelclair 1Etoposide 1Ethanol 1Arsenic Trioxide 1Aminolevulinic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Oligodendroglioma × Aminolevulinic Acid × Clear all
NCT02119338 2017-01-06

5-ALA in Recurrent Glioma

St. Joseph's Hospital and Medical Center, Phoenix

Phase NA Unknown
60 enrolled
CNS

Astrocytoma, Glioblastoma, Glioma, Oligodendroglioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡